Segui
Valeria Fumagalli
Valeria Fumagalli
Email verificata su hsr.it
Titolo
Citata da
Citata da
Anno
Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming
AP BÚnÚchet, G De Simone, P Di Lucia, F Cilenti, G Barbiera, N Le Bert, ...
Nature 574 (7777), 200-205, 2019
1812019
A subset of Kupffer cells regulates metabolism through the expression of CD36
C BlÚriot, E Barreby, G Dunsmore, R Ballaire, S Chakarov, X Ficht, ...
Immunity 54 (9), 2101-2116. e6, 2021
1252021
Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming
G De Simone, F Andreata, C Bleriot, V Fumagalli, C Laura, ...
Immunity 54 (9), 2089-2100. e8, 2021
922021
Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion
V Fumagalli, M RavÓ, D Marotta, P Di Lucia, C Laura, E Sala, M Grillo, ...
Science Immunology 7 (67), eabl9929, 2021
732021
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models
A Conforti, E Marra, F Palombo, G Roscilli, M RavÓ, V Fumagalli, A Muzi, ...
Molecular Therapy 30 (1), 311-326, 2022
602022
Effector CD8+ T cell-derived interleukin-10 enhances acute liver immunopathology
J Fioravanti, P Di Lucia, D Magini, F Moalli, C Boni, AP Benechet, ...
Journal of hepatology 67 (3), 543-548, 2017
552017
SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence
U Gioia, S Tavella, P MartÝnez-Orellana, G Cicio, A Colliva, M Ceccon, ...
Nature Cell Biology 25 (4), 550-564, 2023
472023
Serum HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV infection
V Fumagalli, P Di Lucia, V Venzin, EB Bono, R Jordan, CR Frey, ...
Journal of Experimental Medicine 217 (11), e20200298, 2020
422020
Group 1 ILCs regulate T cell–mediated liver immunopathology by controlling local IL-2 availability
V Fumagalli, V Venzin, P Di Lucia, F Moalli, X Ficht, G Ambrosi, L Giustini, ...
Science immunology 7 (68), eabi6112, 2022
232022
Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection
K Pekayvaz, A Leunig, R Kaiser, M Joppich, S Brambs, A Janjic, O Popp, ...
Nature Communications 13 (1), 1018, 2022
222022
Update on enantiomeric composition of (1 R)-(+)-and (1 S)-(–)-camphor in essential oils by enantioselective gas chromatography
F Tateo, M Bononi, E De Dominicis, V Fumagalli
Analytical Communications 36 (4), 149-151, 1999
221999
Isolation of mouse Kupffer cells for phenotypic and functional studies
F Andreata, C BlÚriot, P Di Lucia, G De Simone, V Fumagalli, X Ficht, ...
STAR protocols 2 (4), 100831, 2021
132021
Nirmatrelvir treatment of SARS‐CoV‐2‐infected mice blunts antiviral adaptive immune responses
V Fumagalli, P Di Lucia, M RavÓ, D Marotta, E Bono, S Grassi, L Donnici, ...
EMBO molecular medicine 15 (5), e17580, 2023
122023
Pyrimidine de novo synthesis inhibition selectively blocks effector but not memory T cell development
S Scherer, SG Oberle, K Kanev, AK Gerullis, M Wu, GP de Almeida, ...
Nature immunology 24 (3), 501-515, 2023
82023
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine
A Grandi, M Tomasi, I Ullah, C Bertelli, T Vanzo, S Accordini, A Gagliardi, ...
Vaccines 11 (10), 1546, 2023
72023
CD8 cis-targeted IL-2 drives potent antiviral activity against hepatitis B virus
F Andreata, KD Moynihan, V Fumagalli, P Di Lucia, DC Pappas, ...
Science Translational Medicine 16 (729), eadi1572, 2024
62024
The interplay of drug therapeutics and immune responses to SARS-CoV-2
V Fumagalli, M Iannacone
Cellular & Molecular Immunology 21 (2), 197-200, 2024
52024
Preclinical evaluation of therapeutic vaccines for chronic hepatitis B that stimulate antiviral activities of T cells and NKT cells
AH Mooney, SL Draper, OK Burn, RJ Anderson, BJ Compton, C Tang, ...
JHEP Reports 6 (5), 101038, 2024
32024
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination
V Fumagalli, M RavÓ, D Marotta, P Di Lucia, EB Bono, L Giustini, ...
Nature Immunology 25 (4), 633-643, 2024
12024
Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral responses against coronaviruses
L Mazzarella, F Santoro, R Ravasio, V Fumagalli, PE Massa, ...
Science Signaling 16 (816), eade0326, 2023
12023
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20